195 related articles for article (PubMed ID: 22160733)
1. Convulsions associated with the use of a synthetic cannabinoid product.
Schneir AB; Baumbacher T
J Med Toxicol; 2012 Mar; 8(1):62-4. PubMed ID: 22160733
[TBL] [Abstract][Full Text] [Related]
2. 'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.
Gugelmann H; Gerona R; Li C; Tsutaoka B; Olson KR; Lung D
Clin Toxicol (Phila); 2014 Jul; 52(6):635-8. PubMed ID: 24905571
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
4. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
6. A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
Schwartz MD; Trecki J; Edison LA; Steck AR; Arnold JK; Gerona RR
J Emerg Med; 2015 May; 48(5):573-80. PubMed ID: 25726258
[TBL] [Abstract][Full Text] [Related]
7. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoid intoxication: a case series and review.
Harris CR; Brown A
J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
[TBL] [Abstract][Full Text] [Related]
9. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
Järbe TUC; Raghav JG
Curr Top Behav Neurosci; 2017; 32():263-281. PubMed ID: 27753006
[TBL] [Abstract][Full Text] [Related]
10. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
McQuade D; Hudson S; Dargan PI; Wood DM
Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
[TBL] [Abstract][Full Text] [Related]
11. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
12. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
Hopkins CY; Gilchrist BL
J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
[TBL] [Abstract][Full Text] [Related]
13. The secret "spice": an undetectable toxic cause of seizure.
de Havenon A; Chin B; Thomas KC; Afra P
Neurohospitalist; 2011 Oct; 1(4):182-6. PubMed ID: 23983854
[TBL] [Abstract][Full Text] [Related]
14. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
15. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
[TBL] [Abstract][Full Text] [Related]
18. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
[TBL] [Abstract][Full Text] [Related]
19. Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015.
Riederer AM; Campleman SL; Carlson RG; Boyer EW; Manini AF; Wax PM; Brent JA;
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(27):692-5. PubMed ID: 27413997
[TBL] [Abstract][Full Text] [Related]
20. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
Cairns R; Brown JA; Gunja N; Buckley NA
Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
